Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

5337 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
59-1  MonoFer® Pharmacosmos A/S Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-2  MonoFer® Pharmacosmos A/S Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-3  MonoFer® Pharmacosmos A/S Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-4  Austedo (安泰坦) Teva Branded Pharmaceutical Products R&D Inc. Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-5  Austedo (安泰坦) Teva Branded Pharmaceutical Products R&D Inc. Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-6  Austedo (安泰坦) Teva Branded Pharmaceutical Products R&D Inc. Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-7  Pifeltro (沛卓) Merck Sharp & Dohme B.V. Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-8  Delstrigo Merck Sharp & Dohme B.V. Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-9  Movicol (默维可) Bridging Pharma Limited Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs
59-10  / B. Braun Melsungen AG Original drug sold in China Original drug imported to China The 59th Batch of Reference Listed Drugs